MiMARK Information

At MiMark, we believe that diagnosing a disease should never add more suffering to patients. That’s why we’ve developed a revolutionary diagnostic approach that uses gynecological fluids to diagnose gynecological diseases efficiently and accurately. Our mission is clear: to make gynecological diagnosis simpler, safer, and more human – for patients, clinicians, and healthcare systems alike. *Disease is complicated. Diagnosis shouldn't be.* For decades, women's health has been underestimated in research and diagnostics.Existing tests for gynecological diseases are often invasive, painful, costly, and sometimes inconclusive. At MiMark, we are changing that reality by developing protein-based diagnostics that extract clinical insights from a simple, minimally invasive gynecological sample. Our work is grounded in science, designed with empathy, and built to transform healthcare globally. *Our Platform: GyLDa - Science that flows naturally.* In MiMark, we have standardized the handling of gynecological fluid samples to ensure reproducibility, stability, and seamless implementation in clinical laboratories. We have developed a curated pipeline that translates protein biomarker candidates from high-throughput Mass Spectrometry Data into Proprietary Key Reagents development and validated Immunoassays. Our pipeline includes GyLDEC, for endometrial cancer diagnosis, and GyLDENDO, for endometriosis diagnosis. Discover more in our Website (see the link below).